Peer-reviewedCC BYCurrent issues in molecular biology
Emapalumab in IFN-γ-Driven Hyperinflammatory Disorders: Mechanisms, Clinical Evidence, and Emerging Therapeutic Applications
Related
- Thioredoxin system: mechanisms and therapeutic potential in mental disorders
- Emerging roles of m6A in female reproductive disorders: from molecular mechanisms to therapeutic targets
- Carbazole derivatives as privileged scaffolds for kinase inhibition: advances in design, therapeutic applications and mechanisms
- Glymphatic system impairment in neurological disorders: potential mechanisms and therapeutic targets
- Plant-derived extracellular vesicles in musculoskeletal disorders: a narrative review of mechanisms, therapeutic efficacy, and translational prospects
BibTeX
@article{anon2026emapalumab,
title = {{Emapalumab in IFN-γ-Driven Hyperinflammatory Disorders: Mechanisms, Clinical Evidence, and Emerging Therapeutic Applications}},
journal = {Current issues in molecular biology},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13702908},
note = {CC BY},
}
RIS
TY - JOUR
TI - Emapalumab in IFN-γ-Driven Hyperinflammatory Disorders: Mechanisms, Clinical Evidence, and Emerging Therapeutic Applications
PY - 2026
DA - 2026/09/24
JO - Current issues in molecular biology
UR - https://europepmc.org/article/PMC/PMC13702908
SN - 1467-3037
SN - 1467-3045
ER -